Controversial appointee rocks FDA like "an atom bomb," scientists there say
Controversial appointee rocks FDA like "an atom bomb," scientists there say

The Trump administration’s elevation of Dr. Tracy Beth Høeg to lead a high-profile office within the Food and Drug Administration is raising alarm among multiple senior FDA officials.
Read the full article on CBS Politics
Truth Analysis
Analysis Summary:
The article's claim about Dr. Tracy Beth Høeg's appointment causing alarm within the FDA is difficult to verify definitively with the provided sources. The sources do not directly address the appointment or the reactions of FDA officials. Therefore, the factual accuracy is low, and the bias is moderate due to the negative framing and reliance on unnamed sources.
Detailed Analysis:
- Claim: The Trump administration's elevation of Dr. Tracy Beth Høeg to lead a high-profile office within the Food and Drug Administration is raising alarm among multiple senior FDA officials.
- Assessment: Unverified. None of the provided sources mention Dr. Tracy Beth Høeg, her appointment, or the reactions of FDA officials. Therefore, this claim cannot be verified or contradicted based on the provided information.
